Carbonic Anhydrase-IX Is a Specific and Sensitive Theragnostic Target for Imaging and Radioimmunotherapy in Metastatic Colorectal Cancer
Our results demonstrate that CA-IX is a relevant target for a theragnostic strategy in mCRC, and provide the first demonstration in clinically-relevant models of metastasis that radiolabeled girentuximab can be used as a scouting agent to stratify and monitor mCRC patients and as a therapeutic alternative for patients with CA-IX-expressing tumors.
Authors
- Wagner Ra
- Pd Roselt
- P.S. Donnelly
- A. Noor
- S. Lee
- B. Blyth
- J.K. Van Zuylekom
- A.G. Heriot
- B. Loveday
- T. Vu
- K. Waldeck
- F. Hollande
- D. Swaroop
- J. Smith
Institutions
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- Victorian Curriculum and Assessment Authority (AU)
- Victorian Comprehensive Cancer Centre (AU)
Publication Details
- Journal
- Gastro Hep Advances
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1016/j.gastha.2025.100871
- Primary Topic
- Enzyme function and inhibition
- Type
- article
- Field-Weighted Citation Impact
- 0.00